Tel: | +86-21-31433387 |
+86-15618786686 | |
Email: | sales@rechemscience.com |
info@rechemscience.com | |
QQ: | 1369748377 |
Skype: | sales@rechemscience.com |
![]() |
Upadacitinib (ABT-494)
|
CAS NO.:1310726-60-3
Molecular Formula:C17H19F3N6O
Molecular Weight:380.367573022842
Purity: > 98%
Solubility (R.T.: 25℃): DMSO
Stability: - 20℃ 2 years
Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) is used in development for the treatment of several autoimmune disorders[1] |
Packing: 10mg/50mg/100mg/500mg/1g and we provide a variety of packaging.
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to sales@rechemscience.com
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days.